Infusion Devices Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Infusion Pumps [Volumetric Pumps, Syringe Pumps, Insulin Pumps, Patient Control Analgesia (PCA) Pu

The infusion devices market is expected to reach US$ 23.08 billion by 2031 from US$ 13.73 billion in 2023; the market is estimated to grow at a CAGR of 6.7% during 2023–2031. Major factors driving the market growth include increasing prevalence of cancer and growing geriatric population. Further, strategic initiatives by market players are likely to boost the market during the forecast period. However, frequent product recalls of infusion devices are among the market deterrents.

Advancements in healthcare are increasing life expectancy globally, leading to a global rise in the geriatric population. According to the US Census Bureau, the number of people in the US aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050, which is a 47% increase. Additionally, in the US, the percentage of the total population of 65 and above is projected to rise from 17% in 2022 to 23% in 2050. According to Statistics Canada, approximately one in five people in Canada (i.e., 18.8% of the population or 7,329,910 people) were at least 65 in 2022. In 2022 approximately 20% of the population in Canada is aged 65 years and above. Furthermore, population projections suggest that 21–29% of the people in Canada are estimated to be aged 65 or above by 2068.

As per the WHO, by 2030, one in 6 people in the world will be 60 years or more. One billion people were reported to be 60 and above in 2020 and the number is expected to reach 1.4 billion in 2030 and 2.1 billion by 2050. WHO also stated that by 2050, 80% of older people will be living in low- and middle-income countries. Additionally, as per the Population Reference Bureau, Asia and Europe have the oldest population. Japan ranks first with 28% of geriatric population, followed by Italy with 23%. Finland, Portugal, and Greece are among the top five countries with ~22% of geriatric population.

A few key benefits of infusion therapy used for geriatric populations are listed below.

Rehydration and Electrolyte Balance: Dehydration can be a higher risk for older people due to factors such as decreased urge to drink fluids, certain medications, and changes in kidney function. IV fluids help seniors maintain the necessary hydration and electrolyte levels for overall health.
Improved Nutritional Status: Consumption and absorption of the required nutrient become challenging with age, increasing the risk of chronic illnesses. Infusion therapy provides essential minerals, vitamins, and amino acids efficiently into the bloodstream and eases the process of nutrient uptake.
Enhanced Immune Function: Immune systems need extra support at an older age as they become more vulnerable to infections. Infusion therapy can deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly to the body.
Pain Management: The senior population majorly suffers from chronic pain, affecting their quality of life. Infusion therapy can quickly and effectively manage pain by delivering medication directly into the bloodstream, reducing inflammation and providing relief.

Thus, the increasing geriatric population drives the demand for infusion devices across the globe

The comparative company analysis evaluates and categorizes the infusion devices market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Infusion Devices Market. The key market players are Becton Dickinson and Co, Fresenius Kabi AG, B Braun SE, CODAN US Corp, Baxter International Inc, Elimedical Inc, ICU Medical Inc, BPL Medical Technologies Pvt Ltd, Nipro Corp, KD Scientific Inc, Medtronic Plc, Zimed Healthcare Ltd, Terumo Corp, Eitan Medical Ltd, Polymedicure, Moog Inc, Tandem Diabetes Care Inc.

Based on product type, the infusion devices market is segmented into Infusion Pumps and Infusion Sets. In 2023, the Infusion Pumps segment held the largest share of the market. The infusion pumps segment is further segmented into volumetric pumps, syringe pumps, insulin pumps, patient control analgesia (pca) pumps, enteral pumps, implantable pumps, and elastomeric pumps. The infusion sets segment is further segmented into vented infusion sets and non-vented infusion sets. Based on application, the infusion devices market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. In 2023, the diabetes segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the infusion devices market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the Infusion Devices Market are listed below.

In May 2024, Moog Inc. received US FDA 510(k) clearance for CURLIN 8000 Ambulatory Infusion System. This premium infusion platform was developed specifically for use in home infusion settings. The CURLIN 8000 combines a reliable and robust design with a simple, intuitive user interface designed for easy navigation by both clinical and non-clinical users. The CURLIN 8000 also integrates seamlessly with CURLIN RxManager, a completely new medication safety software developed to complement existing home infusion workflows.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the infusion devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global infusion devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.